Review
Endocrinology & Metabolism
Jacob Bar-Tana
Summary: 'Glucolipotoxicity' and 'insulin resistance' are believed to drive type 2 diabetes and metabolic syndrome, but recent treatments show that alleviating non-glycemic and cardio-renal diseases is possible regardless of glucose lowering and insulin resistance. This opinion article proposes replacing the current paradigm with an 'mammalian target of rapamycin complex 1 (mTORC1) syndrome' (TorS) paradigm, which includes various diseases and may generate novel treatments.
TRENDS IN ENDOCRINOLOGY AND METABOLISM
(2023)
Article
Multidisciplinary Sciences
Elizabeth Haythorne, Matthew Lloyd, John Walsby-Tickle, Andrei Tarasov, Jonas Sandbrink, Idoia Portillo, Raul Terron Exposito, Gregor Sachse, Malgorzata Cyranka, Maria Rohm, Patrik Rorsman, James McCullagh, Frances M. Ashcroft
Summary: Chronic hyperglycemia impairs insulin secretion and leads to diabetes. It has been found that a glucose metabolite is responsible for this effect, and reducing glucose metabolism during hyperglycemia can prevent the loss of beta-cell function.
NATURE COMMUNICATIONS
(2022)
Article
Biochemistry & Molecular Biology
Samuel Ogden, Kashmala Carys, Ibrahim Ahmed, Jason Bruce, Andrew D. Sharrocks
Summary: This study reveals the adaptability of OAC cells to ERBB2 inhibition in a drug resistant state, with HNF4A and PPARGC1A playing key roles in this process.
Review
Cell Biology
Paola Falletta, Colin R. Goding, Yurena Vivas-Garcia
Summary: Melanoma is a complex and aggressive cancer type with different cell subpopulations displaying distinct phenotypes within the tumor. These subpopulations undergo metabolic reprogramming, allowing them to adapt to changing environments and mutations. Different metabolic profiles are associated with specific phenotypes, enabling adaptation to hostile conditions and promoting invasion and metastasis.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2022)
Article
Pharmacology & Pharmacy
Shiwei Zhou, Obinna N. Obianom, Jiangsheng Huang, Dong Guo, Hong Yang, Qing Li, Yan Shu
Summary: Genetic evidence has shown that pyrvinium can improve glucose and lipid metabolism by lowering beta-catenin levels and activating AMPK, reducing glucose production and lipogenesis, and showing potential for treating metabolic disorders in mice fed with high-fat diet.
Article
Biochemistry & Molecular Biology
Ming-Yue Li, Li-Zhong Liu, Qihang Xin, Jiaying Zhou, Xiaoyang Zhang, Rui Zhang, Zangshu Wu, Junbo Yi, Ming Dong
Summary: Pancreatic fi-cell apoptosis is a key feature of diabetes and can be induced by chronic exposure to saturated fatty acids. This study evaluated the role of Mcl-1 and mTOR in high-fat-diet-induced diabetes in mice and palmitic acid-exposed fi-cells. The results showed that the dysregulation of Mcl-1 and mTOR led to fi-cell apoptosis and impaired insulin secretion, providing potential therapeutic targets for diabetes.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
(2023)
Article
Multidisciplinary Sciences
Zeenat Rashida, Rajalakshmi Srinivasan, Meghana Cyanam, Sunil Laxman
Summary: In changing environments, cells modulate resource budgeting through distinct metabolic routes to control growth. The TORC1 and SNF1/AMPK pathways operate contrastingly in nutrient replete or limited environments to maintain homeostasis. Kog1, a modified form of yeast TORC1 component, plays a crucial role in regulating SNF1/AMPK activity and outputs during glucose and amino acid limitations, facilitating effective carbon allocation and metabolic flux.
Article
Medicine, Research & Experimental
Jennifer A. Schaub, Fadhl M. AlAkwaa, Phillip J. McCown, Abhijit S. Naik, Viji Nair, Sean Eddy, Rajasree Menon, Edgar A. Otto, Dawit Demeke, John Hartman, Damian Fermin, Christopher L. O'Connor, Lalita Subramanian, Markus Bitzer, Roger Harned, Patricia Ladd, Laura Pyle, Subramaniam Pennathur, Ken Inoki, Jeffrey B. Hodgin, Frank C. Brosius III, Robert G. Nelson, Matthias Kretzler, Petter Bjornstad
Summary: This study analyzed kidney biopsies from type 2 diabetes patients and healthy controls, and found that SGLT2 inhibitor treatment mitigates diabetes-induced metabolic perturbations through suppression of the mTORC1 signaling pathway in kidney tubules. The treatment with SGLT2 inhibitors also affected transcriptional processes in different segments of the renal tubules.
JOURNAL OF CLINICAL INVESTIGATION
(2023)
Article
Multidisciplinary Sciences
Mareike Grotheer, Mona Rosenke, Hua Wu, Holly Kular, Francesca R. Querdasi, Vaidehi S. Natu, Jason D. Yeatman, Kalanit Grill-Spector
Summary: In this study, the development of white matter in infants from 0 to 6 months was investigated using diffusion MRI and quantitative MRI measurements. The researchers found that the longitudinal relaxation rate (R1) of white matter increased over time, with faster development in less mature areas of white matter in newborns.
NATURE COMMUNICATIONS
(2022)
Article
Multidisciplinary Sciences
Ting Yuan, Karthika Annamalai, Shruti Naik, Blaz Lupse, Shirin Geravandi, Anasua Pal, Aleksandra Dobrowolski, Jaee Ghawali, Marina Ruhlandt, Kanaka Durga Devi Gorrepati, Zahra Azizi, Dae-Sik Lim, Kathrin Maedler, Amin Ardestani
Summary: LATS2, a core component of the Hippo signaling pathway, is activated under diabetic conditions and induces beta-cell failure. Inhibiting LATS2 can improve beta-cell viability and insulin secretion, suggesting it as a potential therapeutic target for improving pancreatic beta-cell survival in diabetes.
NATURE COMMUNICATIONS
(2021)
Article
Multidisciplinary Sciences
Kibum Kim, Hee Chan Yoo, Byung Gyu Kim, Sulhee Kim, Yulseung Sung, Ina Yoon, Ya Chun Yu, Seung Joon Park, Jong Hyun Kim, Kyungjae Myung, Kwang Yeon Hwang, Sunghoon Kim, Jung Min Han
Summary: This study reveals that under glucose starvation, intracellular leucine sensor LARS1 is O-GlcNAcylated, which regulates mTORC1 activity and leucine metabolism, impacting the utilization of glucose and leucine.
NATURE COMMUNICATIONS
(2022)
Article
Nutrition & Dietetics
Kouji Fukuyama, Eishi Motomura, Motohiro Okada
Summary: Lurasidone and quetiapine are effective atypical mood-stabilizing antipsychotics, but have different effects on weight gain and metabolic complications. The underlying reasons for these differences are still unknown.
Article
Multidisciplinary Sciences
Lauren A. Callender, Johannes Schroth, Elizabeth C. Carroll, Conor Garrod-Ketchley, Lisa E. L. Romano, Eleanor Hendy, Audrey Kelly, Paul Lavender, Arne N. Akbar, J. Paul Chapple, Sian M. Henson
Summary: This study investigates the role of GATA3 in regulating mitochondrial mass and biogenesis in CD4(+) T cells in response to DNA damage, through the actions of AMPK. The findings expand the understanding of the pleiotropic interactions of GATA3 and suggest the potential for GATA3-targeted interventions in CD4(+) T cell viability and function after DNA damage.
NATURE COMMUNICATIONS
(2021)
Article
Plant Sciences
Yang Jin, Huanhuan Pang, Lihong Zhao, Fangyi Zhao, Ziqian Cheng, Qianqian Liu, Ranji Cui, Wei Yang, Bingjin Li
Summary: This study aimed to investigate the antidepressant-like effects of the compatibility of ginseng total saponins (GTS) and Fuzi total alkaloids (FTA) in ovariectomized mice and the potential mechanisms. The results showed that the combination of GTS and FTA exhibited significant antidepressant effects in the model of menopausal depression, which were mediated through the activation of BDNF-mTORC1 signaling, regulation of autophagy, and modulation of hippocampal synaptic plasticity. Furthermore, metabolomic analysis revealed that the combination treatment also affected the peripheral lipid profiles, providing potential biomarkers for the antidepressant-like effects.
Article
Multidisciplinary Sciences
Xiaojie Ma, Yunkun Lu, Ziyu Zhou, Qin Li, Xi Chen, Weiyun Wang, Yan Jin, Zhensheng Hu, Guo Chen, Qian Deng, Weina Shang, Hao Wang, Hongxing Fu, Xiangwei He, Xin-Hua Feng, Saiyong Zhu
Summary: Through chemical screening, the BET inhibitor I-BET151 is found to promote the expansion of pancreatic progenitors (PPs) and facilitate their differentiation into functional beta cells. Transplantation of these cells shows promising results in ameliorating diabetes. The study highlights the significance of epigenetic and transcriptional modulations in lineage-specific progenitor self-renewal.
Review
Cell Biology
Roy Anindya, Guy A. Rutter, Gargi Meur
Summary: In this article, the dynamic interaction between pancreatic beta cells, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the host immune system in new-onset type 1 diabetes (T1D) is detailed. It is shown that beta cells express the necessary receptors for SARS-CoV-2 entry and can be infected. However, beta cell expansion and regeneration may effectively compensate for lost beta cells. The appearance of islet autoantibodies following SARS-CoV-2 infection suggests a breakdown of immune tolerance, but many cases also indicate a progression of pre-existing diabetes rather than new-onset T1D.
IMMUNOLOGY AND CELL BIOLOGY
(2023)
Article
Pharmacology & Pharmacy
Darmiga Thayabaran, Anson P. T. Tsui, Stefan Ebmeier, Jaimini Cegla, Alessia David, Ben Jones
Summary: Adjusting LDL-C for Lp(a)-cholesterol improves the accuracy of FH diagnostic tools but may lead to misclassification of mutation-positive patients. Health economic analysis is required to balance the risks of over- and under-diagnosis.
JOURNAL OF CLINICAL LIPIDOLOGY
(2023)
Article
Endocrinology & Metabolism
Parizad Avari, Pei Chia Eng, Ming Hu, Runzhi Chen, Natalija Popovic, Constantin Polychronakos, Duncan Spalding, Guy A. Rutter, Nick Oliver, Florian Wernig
Summary: This article reports a case of a proinsulinoma with suppressed insulin and C-peptide levels. It suggests that low insulin and C-peptide levels do not always indicate the absence of a neuroendocrine islet cell tumor, and elevated proinsulin levels may be an indicator for diagnosis.
JOURNAL OF THE ENDOCRINE SOCIETY
(2023)
Review
Biochemistry & Molecular Biology
Guy A. Rutter, Vaibhav Sidarala, Brett A. Kaufman, Scott A. Soleimanpour
Summary: The regulation of glucose-regulated insulin secretion in diabetes is defective. This review focuses on the role of glucose's privileged oxidative metabolism in glucose detection, the regulation of mitochondrial metabolism by Ca2+, and the importance of mitochondrial structure and dynamics in beta cells. Additionally, it highlights the contributions of Professor Randle and his colleagues towards our understanding of insulin secretion regulation.
BIOCHEMICAL JOURNAL
(2023)
Article
Endocrinology & Metabolism
Jiannan Xiao, Liliane El Eid, Teresa Buenaventura, Raphael Boutry, Amelie Bonnefond, Ben Jones, Guy A. Rutter, Philippe Froguel, Alejandra Tomas
Summary: This study aimed to determine the kinase activity profiles of human pancreatic beta cells downstream of glucagon-like peptide-1 receptor (GLP-1R) balanced versus biased agonist stimulations. The results showed that acute and sustained GLP-1R agonist exposure had distinct effects on kinase responses, and different biased agonists could modulate distinct kinase interaction networks. These findings have important implications for the selection of appropriate anti-type 2 diabetes therapies.
DIABETES OBESITY & METABOLISM
(2023)
Article
Medicine, Research & Experimental
Pauline Chabosseau, Fiona Yong, Luis F. Delgadillo-Silva, Eun Young Lee, Rana Melhem, Shiying Li, Nidhi Gandhi, Jules Wastin, Livia Lopez Noriega, Isabelle Leclerc, Yusuf Ali, Jing W. Hughes, Robert Sladek, Aida Martinez-Sanchez, Guy A. Rutter
Summary: Spatially-organized increases in Ca2+ within pancreatic beta cells under high glucose stimulation were found to be mediated by leader cells, which possess unique molecular features and localized signaling with delta cells. Single cell RNA sequencing revealed differential gene expression related to cilium biogenesis and transcriptional regulation between leader and follower cells.
Article
Multidisciplinary Sciences
Roderick C. Slieker, Louise A. Donnelly, Elina Akalestou, Livia Lopez-Noriega, Rana Melhem, Aysim Gunes, Frederic Abou Azar, Alexander Efanov, Eleni Georgiadou, Hermine Muniangi-Muhitu, Mahsa Sheikh, Giuseppe N. Giordano, Mikael Akerlund, Emma Ahlqvist, Ashfaq Ali, Karina Banasik, Soren Brunak, Marko Barovic, Gerard A. Bouland, Frederic Burdet, Mickael Canouil, Iulian Dragan, Petra J. M. Elders, Celine Fernandez, Andreas Festa, Hugo Fitipaldi, Phillippe Froguel, Valborg Gudmundsdottir, Vilmundur Gudnason, Mathias J. Gerl, Amber A. van der Heijden, Lori L. Jennings, Michael K. Hansen, Min Kim, Isabelle Leclerc, Christian Klose, Dmitry Kuznetsov, Dina Mansour Aly, Florence Mehl, Diana Marek, Olle Melander, Anne Niknejad, Filip Ottosson, Imre Pavo, Kevin Duffin, Samreen K. Syed, Janice L. Shaw, Over Cabrera, Timothy J. Pullen, Kai Simons, Michele Solimena, Tommi Suvitaival, Asger Wretlind, Peter Rossing, Valeriya Lyssenko, Cristina Legido Quigley, Leif Groop, Bernard Thorens, Paul W. Franks, Gareth E. Lim, Jennifer Estall, Mark Ibberson, Joline W. J. Beulens, Leen M't Hart, Ewan R. Pearson, Guy A. Rutter
Summary: We identified biomarkers for disease progression in type 2 diabetes cohorts, including metabolites, lipids, and proteins. Various substances such as homocitrulline, isoleucine, 2-aminoadipic acid, triacylglycerol species, and sphingomyelin 42:2;2 levels were found to predict faster progression towards insulin requirement. Proteins like GDF15/MIC-1, IL-18Ra, CRELD1, NogoR, FAS, and ENPP7 were associated with faster progression, while others like SMAC/DIABLO, SPOCK1, and HEMK2 predicted slower progression rates. The findings also suggested possible disease mechanisms and potential therapeutic avenues to slow diabetes progression.
NATURE COMMUNICATIONS
(2023)
Article
Endocrinology & Metabolism
M. V. Surekha, N. Suneetha, N. Balakrishna, Uday Kumar Putcha, K. Satyanarayana, J. J. Babu Geddam, Pagidoju Sreenu, B. Tulja, Raja Sriswan Mamidi, Guy A. Rutter, Gargi Meur
Summary: This study found that asymptomatic SARS-CoV-2 infection during pregnancy appears to be associated with various abnormal placental histopathologic changes related to placental hypoxia, independent of maternal anemia status. These findings support the independent role of SARS-CoV-2 in causing placental hypoxia in pregnant women.
FRONTIERS IN ENDOCRINOLOGY
(2023)
Article
Endocrinology & Metabolism
George Firth, Eleni Georgiadou, Alexander Griffiths, Maral Amrahli, Jana Kim, Zilin Yu, Ming Hu, Theodora J. Stewart, Isabelle Leclerc, Haruka Okamoto, Daniel Gomez, Philip J. Blower, Guy A. Rutter
Summary: Common variants in the SLC30A8 gene are associated with altered risk of type 2 diabetes, while rare loss-of-function variants in the gene are protective against the disease. This study found that the R138X mutation in the mouse SLC30A8 gene affects zinc and manganese homeostasis, leading to increased levels of these metals in pancreatic beta cells and improved insulin secretion.
FRONTIERS IN ENDOCRINOLOGY
(2023)
Article
Medicine, Research & Experimental
Alice Adriaenssens, Johannes Broichhagen, Anne de Bray, Julia Ast, Annie Hasib, Ben Jones, Alejandra Tomas, Natalie Figueredo Burgos, Orla Woodward, Jo Lewis, Elisabeth O'Flaherty, Kimberley El, Canqi Cui, Norio Harada, Nobuya Inagaki, Jonathan Campbell, Daniel Brierley, David J. Hodson, Ricardo Samms, Fiona Gribble, Frank Reimann
Summary: The signaling pathways of the central glucose-dependent insulinotropic polypeptide (GIP) receptor (GIPR) in the brain are not fully understood, and its role in GIP-based therapeutics for weight loss is critical. This study found that Gipr neurons in the hypothalamus and dorsal vagal complex (DVC) play a role in the control of energy balance, but they have different connectivity, transcriptomic profiles, and appetite-controlling mechanisms. The study also showed that GIPR agonists have restricted access to the central nervous system, primarily targeting circumventricular organs. These findings highlight the heterogeneity of the central GIPR signaling axis and suggest the need to consider multiple regulatory pathways in studying the effects of GIP pharmacology on feeding behavior.
Review
Endocrinology & Metabolism
Peter J. Thompson, Jasmine Pipella, Guy A. Rutter, Herbert Y. Gaisano, Pere Santamaria
Summary: Type 1 diabetes occurs when the body's immune system mistakenly attacks and destroys pancreatic beta cells. This review highlights recent advances in understanding how early life exposures and stress response pathways impact beta cells and contribute to the autoimmune process in type 1 diabetes. Progress in this area holds promise for developing targeted therapies that could be implemented in the early stages of the disease, potentially in combination with immunotherapies.
Article
Endocrinology & Metabolism
Yusman Manchanda, Stavroula Bitsi, Shiqian Chen, Johannes Broichhagen, Jorge Bernardino de la Serna, Ben Jones, Alejandra Tomas
Summary: The incretin receptors, GLP-1R and GIPR, are important therapeutic targets for type 2 diabetes and obesity. While GLP-1R has been favored as a therapeutic target due to blunted GIPR responses in T2D patients, recent developments have renewed interest in GIPR biology. Our study compares the surface expression, trafficking, and signaling characteristics of both receptors in pancreatic beta cells, identifying potential differences that might underlie distinct pharmacological responses associated with each receptor.
Meeting Abstract
Endocrinology & Metabolism
S. J. Millership, V. Yu, F. Yong, A. Marta, K. Chen, E. Georgiadou, S. Bhattacharya, N. Parveen, S. Khadayate, Z. Stamoulis, Y. Ali, S. Dhawan, D. J. Withers, G. A. Rutter
Article
Medicine, Research & Experimental
Wing Yan So, Yilie Liao, Wai Nam Liu, Guy A. Rutter, Weiping Han
Summary: PAX6 plays a critical role in the survival of pancreatic beta cells and is down-regulated under diabetic conditions. Overexpression of PAX6 promotes beta cell survival and improves glycemic control after islet transplantation.
EMBO MOLECULAR MEDICINE
(2023)